logo.jpg
Global LAG 3 Antibody FDA Approval Clinical Trials LAG 3 Inhibitors Market Future Growth Opportunity Insight
October 04, 2024 06:57 ET | KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global LAG-3 Inhibitors Market, Drug Sales, & Clinical Trials Insight 2029 Report Highlights: Global LAG-3 Inhibitors Market Opportunity: > USD 3...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
October 03, 2024 16:00 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), the Spatial Biology Company®, today announced Scott Mendel has been appointed as Chairman of...
klaw.png
Kuehn Law Encourages SMAR, MNTX, CPTN, and SMC Investors to Contact Law Firm
October 03, 2024 09:17 ET | KUEHN LAW, PLLC
Kuehn Law Encourages SMAR, MNTX, CPTN, and SMC Investors to Contact Law Firm
GlacierBancorp_Final_Logo.png
Glacier Bancorp, Inc. Announces Third Quarter Earnings Release and Conference Call
October 02, 2024 16:30 ET | Glacier Bancorp, Inc.
KALISPELL, Mont., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI) will report third quarter financial results after the market closes on October 24, 2024. A conference call for...
Kineta Logo.jpg
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1
October 02, 2024 16:05 ET | Kineta, Inc.
TuHURA has extended their exclusivity and right of first offer pursuant to the terms of the agreement. Kineta and TuHURA are collaborating on the ongoing Phase 1/Phase 2 clinical trial in patients...
Firm Logo-with Investor Law Firm.jpg
SMAR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Smartsheet Inc. Is Fair to Shareholders
October 02, 2024 15:02 ET | Halper Sadeh LLC
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Smartsheet Inc. (NYSE: SMAR) to funds managed by Blackstone and Vista...
Barton Ridge by Toll Brothers
Toll Brothers Announces New Luxury Home Community, Barton Ridge, Coming Soon to Ann Arbor, Michigan
October 02, 2024 10:00 ET | Toll Brothers, Inc.
ANN ARBOR, Mich., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Barton Ridge, is coming soon...
bjslogo.jpg
BJ’s Restaurants Opens in Cypress, Texas
October 01, 2024 13:00 ET | BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced the opening of its restaurant in Cypress, Texas. The new BJ’s Restaurant &...
David20P.20Shapiro20Criminal20Defense20Attorneys (1).jpg
David P. Shapiro Criminal Defense Attorneys On What To Do After Being Charged With A Crime in San Diego
October 01, 2024 11:53 ET | David P. Shapiro Criminal Defense Attorneys
San Diego, CA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The criminal defense lawyers at David P. Shapiro Criminal Defense Attorneys have received “not guilty” verdicts on everything from DUI charges to...
La combinazione basa
La combinazione basata sulla formulazione sottocutanea (SC) di TALVEY®▼ (talquetamab) e DARZALEX® (daratumumab) evidenzia risposte profonde e durature in pazienti con mieloma multiplo recidivato o refrattario
October 01, 2024 09:17 ET | Janssen Cilag International NV
I dati aggiornati evidenziano una percentuale del 100 per cento di risposta complessiva, con il 56 per cento dei pazienti che ha ottenuto una risposta completa o migliore con il dosaggio settimanale,...